Cryopreserved Placental Membrane Allograft Reduces the Likelihood of Developing a New or Recurring Foot Ulcer and All-Cause Mortality in Diabetic Patients When Compared with Other Cellular- and Tissue-Based Products

OBJECTIVE: To compare outcomes for Medicare patients with diabetic foot ulcer(s) (DFU) receiving cryopreserved placental membrane containing viable cells (vCPM) to other Cellular- and Tissue-Based Products (CTPs). APPROACH: Patients with DFU and CTP use were selected in Medicare claims (2013–2017) b...

Descripción completa

Detalles Bibliográficos
Autores principales: DaVanzo, Joan, Hartzman, Alex, Surfield, Christopher, Dobson, Allen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Technology Advances
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885539/
https://www.ncbi.nlm.nih.gov/pubmed/35262428
http://dx.doi.org/10.1089/wound.2021.0123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885539/
https://www.ncbi.nlm.nih.gov/pubmed/35262428
http://dx.doi.org/10.1089/wound.2021.0123

Ejemplares similares